Annual progress reports
Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.
Annual progress report Yemen 2014
Annual progress report Yemen 2013
Annual progress report Yemen 2012
Annual progress report Yemen 2011
Annual progress report Yemen 2010
Annual progress report Yemen 2009
Annual progress report Yemen 2008
Annual progress report Yemen 2007
Annual progress report Yemen 2006
Annual progress report Yemen 2004
Annual progress report Yemen 2005
Annual progress report Yemen 2003
Annual progress report Yemen 2002
Annual progress report Yemen 2001
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.
Proposal for HSS support 2019: Yemen
Proposal for CCEOP support (2020-2022) : Yemen
Proposal for NVS - MR follow-up campaign 2018: Yemen
Proposal for NVS – IPV support
Proposal for HSS support: Yemen(2)
Proposal for MR Campaign support: Yemen
Proposal for NVS - Rota support: Yemen
Proposal for NVS - Pneumo support: Yemen
Proposal for HSS support: Yemen
Proposal for ISS support: Yemen
Proposal for INS support: Yemen
Proposal for NVS - DTP, Hep B, Hib support: Yemen
Proposal for ISS support: Yemen (2001)
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
cMYPs Yemen 2006-2010
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter HSS Yemen 2021
Decision Letter IPV Yemen 2021
Decision Letter IPV Yemen 2020
Decision Letter PCV Yemen 2020
Decision Letter Penta Yemen 2020
Decision Letter RV Yemen 2020
Decision Letter RV Yemen 2019
Yemen Decision Letter IPV 2019
Yemen Decision Letter ISD 2019
Yemen Decision Letter PCV 2019
Yemen Decision Letter Penta 2019
Yemen Decision Letter Rota 2019
Decision Letter MR campaign Yemen 2018
Decision Letter NVS, Devices Yemen 2018
Decision Letter NVS, Devices Yemen 2017
Decision Letter NVS Yemen 2015
Decision Letter NVS Yemen 2014(2)
Decision Letter NVS Yemen 2014
Decision Letter HSS Yemen 2014
Decision letter NVS Yemen 2013
The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).
HSS evaluation Yemen
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan Yemen 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.